Sec Form 3 Filing - Pure Health Capital Americas 1 SPV RSC LTD @ Ardent Health Partners, Inc. - 2024-07-17

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Pure Health Capital Americas 1 SPV RSC LTD 2. Issuer Name and Ticker or Trading Symbol Ardent Health Partners, Inc. [ ARDT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 2427 RSCO-WORKS03, 24TH FLOOR,, SILA TOWER, ADGM, AL MARYAH ISLAND 3. Date of Earliest Transaction (MM/DD/YY) 07/17/2024 (Street) ABU DHABI, C0POB 283572 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock ( 1 ) ( 2 ) ( 3 ) 30,262,664 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Pure Health Capital Americas 1 SPV RSC LTD 2427 RSCO-WORKS03, 24TH FLOOR, SILA TOWER, ADGM, AL MARYAH ISLAND ABU DHABI, C0POB 283572 X Pure Health Holding PJSC AL DAR HQ BUILDING, 6TH FLOOR, AL RAHA STREET, AL RAHA BEACH, ABU DHABI, C0POB 144443 X Pure Health Medical Supplies LLC 3401 VISION TOWER, AL KHALEEJ AL TEJARI STREET 1, BUSINESS BAY DUBAI, C0POB 283572 X Pure Health Capital LLC 3401 VISION TOWER, AL KHALEEJ AL TEJARI STREET 1, BUSINESS BAY DUBAI, C0POB 283572 X Signatures Pure Health Capital Americas 1 SPV RSC LTD, By: /s/ Farhan Malik , Name: Farhan Malik, Title: Director 07/17/2024 Signature of Reporting Person Date Pure Health Holding PJSC, By: /s/ Farhan Malik, Name: Farhan Malik, Title: Manager 07/17/2024 Signature of Reporting Person Date Pure Health Medical Supplies LLC, By: /s/ Farhan Malik, Name: Farhan Malik, Title: Manager 07/17/2024 Signature of Reporting Person Date Pure Health Capital LLC, By: /s/ Farhan Malik, Name: Farhan Malik, Title: Manager 07/17/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )This statement is jointly filed by Pure Health Capital Americas 1 SPV RSC LTD (PHCA), Pure Health Holding PJSC (PHH), Pure Health Medical Supplies LLC (PHMS) and Pure Health Capital LLC (PHC). PHCA is the direct owner of the securities listed in Table I (the Securities). PHC is the sole shareholder of PHCA. PHMS is the conrolling member of PHC. PHH is the controlling member of PHMS. As a result of these relationships, each of the reporting persons named herein may be deemed to have beneficial ownership of the securities held of record by PHCA. ( 2 )Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer. ( 3 )Each of the reporting persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other reportingpersons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of thereporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission ofbeneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.